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Abstract: Post-traumatic stress disorder (PTSD) continues to attract both empirical and clinical 
interest due to its complex symptom profile and the underlying processes involved. Recently, 
research attention has been focused on the types of memory processes involved in PTSD and 
hypothesized neurobiological processes. Complicating this exploration, and the treatment of 
PTSD, are underlying comorbid disorders, such as depression, anxiety, and substance use 
 disorders. Treatment of PTSD has undergone further reviews with the introduction of eye 
movement desensitization and reprocessing (EMDR). EMDR has been empirically demon-
strated to be as efficacious as other specific PTSD treatments, such as trauma-focused cognitive 
behavioral therapy. There is emerging evidence that there are different processes underlying 
these two types of trauma treatment and some evidence that EMDR might have an efficiency 
advantage. Current research and understanding regarding the processes of EMDR and the future 
direction of EMDR is presented.
Keywords: post-traumatic stress disorder, eye movement desensitization, neurobiological, 
symptoms, treatment, comorbid
Introduction
Post-traumatic stress disorder (PTSD) presents with a complex and diverse set of 
symptoms involving a mixture of social, biological, and psychological processes. 
Adding to the complexity are several comorbid disorders, including mood, anxiety, 
and substance use disorders, traumatic brain injury, grief, and chronic pain. Comorbid 
disorders complicate the identification of predisposing and perpetuating factors, assess-
ment, clarity of primary diagnosis, and selection of treatment plans. Here we present 
a broad overview of PTSD, including its intricate neurobiological and psychological 
symptom profile and common comorbid disorders. Evidence for the effectiveness of 
eye movement desensitization reprocessing (EMDR) is then presented, as well as its 
possible advantages, controversies, and key processes. Finally, the future possibilities 
for EMDR are discussed.
Psychological symptom profile of PTSD
The recently released DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition) identifies a more expansive symptom profile for PTSD than previous 
definitions. The symptom criteria now include re-experiencing, avoidance, negative 
alterations in cognitions and mood, and negative alterations of arousal and reactivity. 
In contrast with the DSM-IV, the type of event that can result in symptoms of PTSD 





has been extended, and differing presentations in children 
and adolescents have been acknowledged.
Perhaps a distinguishing hallmark of PTSD is the intru-
sive experiences, consisting of a sense of reliving the event 
in vivid visual images with physiological responses, and 
auditory and olfactory aspects, all of which occur with the 
same intense feeling of panic and fear as experienced in the 
distressing situation.1–3 An internal or external reminder of 
the event triggers these intrusive experiences, resulting in 
a sense of lack of control over their appearance. Combined 
with the vivid yet fragmented and disorganized presentation 
of such memories, the intrusive symptoms are both distress-
ing and confusing, resulting often in fear of the symptom 
itself.4,5 The fragmented, and sometimes inhibited, storage 
of memories related to the distressing event is another defin-
ing feature of PTSD.4 An inability to place the event in a 
coherent, sequential time line, or to remember elements of 
the event at all, is a distinctive symptom that again causes 
both distress and frustration.
The cycle of fear and retraumatization caused by the 
intrusive symptoms often results in avoidance strategies. 
Avoidance of external and internal stimuli (thoughts and 
feelings) directly associated with the traumatic event can 
be explained as a direct learning experience; however, 
individuals often avoid unrelated situations.3,6 Research has 
demonstrated that avoidance not only results in an increase 
in symptomatology but also results in diminished interest in 
participating in activities, leading to withdrawal and feelings 
of detachment and estrangement from others.3,7 In addition, 
individuals can respond to the distressing event and intrusive 
symptoms with an intense need to self-protect. This manifests 
as symptoms of hyperarousal, including sleep difficulties, 
hypervigilance, and lack of concentration. These heightened 
levels of arousal both feed into and result from a fear response 
cycle, thereby resulting in a constant state of hyperarousal.3 
This combination of symptoms can ultimately result in irrita-
bility, aggression and, at times, self-destructive behaviors.
PTSD continues to be listed as an anxiety disorder in the 
DSM-5, although the centrality of dissociative symptoms 
has been argued.8 Dissociative responses, such as derealiza-
tion and depersonalization, at times referred to as defensive 
responses, and constricted affect or emotional numbing, are 
features of PTSD.6,8 Such symptoms have been shown to 
correlate with the severity of the trauma, fear of death, and 
feelings of helplessness during the traumatic event.8 These 
symptoms can emerge from defense mechanisms that initially 
protect individuals from the reality of their current experi-
ences, but later evolve into maladaptive strategies that do not 
enable consolidation of past experiences. Altogether, PTSD 
symptoms are debilitating and, as time passes, can generalize 
to experiences unrelated to the distressing event. This can 
result in isolation and cognitive distortions affecting one’s 
core sense of self.
Neurobiological symptom  
profile of PTSD
Shalev3 proposed that the complexity of PTSD symptoms 
is best understood as the co-occurrence of several processes 
including: an alteration of neurobiological processes; 
the acquisition of conditioned fear responses to trauma-
related stimuli; and altered cognitive schemata and social 
apprehension. Neuroimaging technology has enabled 
researchers to explore the neurobiological basis of PTSD. 
The research to date presents contrasting results partially 
attributed to methodological differences including age range, 
trauma type, imaging methods, analysis of imaging methods, 
symptom duration, and inclusion of comorbid disorders 
and  medications. Overall, there is building evidence that 
symptomatology following experiences of traumatic stress 
may derive from effects on brain function and structure. 
Less clarity surrounds the exact areas involved and whether 
the differences are predisposing or perpetuating factors 
of PTSD.
Research has demonstrated that following a distressing 
event there is an interruption of the brain’s normal mode of 
processing information.9,10 This includes a failure to create a 
coherent memory of the experience, as all aspects of the 
memory, sensory, thought, and emotionality appear unable 
to be categorized and integrated with other experiences.10 
This may be due to deficits in declarative and non-declarative 
memories that appear to be implicated in PTSD symptoms 
through their impact on conditioned responses, reliving of 
traumatic memories, and fragmentation of memories (both 
autobiographic and trauma-related).9,11
Non-declarative (also known as implicit or procedural) 
memory refers to memories of skills and habits, emotional 
responses, reflexive actions, and classically conditioned 
responses (for example, memories that cannot be willfully 
brought into the conscious mind such as riding a bike).9 
Declarative (also known as explicit) memory refers to con-
scious awareness of facts or events that have happened to 
the individual (for example, remembering facts or lists).12 In 
relation to PTSD, two types of declarative memories appear 
to be of importance, ie, episodic and semantic memories. 
Episodic memories are isolated memories of distinct events 
that form rapidly, with strong and vivid clarity, are rich in 
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sensory detail, and are unambiguous.13 Semantic memories 
are stored as more general knowledge; these are abstracted 
from episodic memories and integrated with other semantic 
memories, creating meaning and understanding of oneself 
in context of the world.13 PTSD symptoms are proposed to 
occur due to a failure of the brain to consolidate and integrate 
episodic memories into the semantic system, resulting in pro-
longed and inappropriate resurfacing of episodic memories of 
traumatic events with no association to other memories.13
Situationally accessible memory is a long-term, image-
based perceptual representation of the incident that is 
accessed automatically, whereas verbally accessible memory 
incorporates representations that reflect more conscious 
attention when being encoded, are accessible, verbalizable, 
and interact with other information in the autographical 
memory. Brewin1 proposes that intrusive flashbacks occur 
when encoding of the event into situationally accessible 
memory is enhanced, and encoding or re-encoding into 
verbally accessible memory is diminished, resulting in the 
memory never being re-encoded into episodic memory. 
Under this hypothesis, a large amount of sensory informa-
tion can be stored and encoded over long periods due to the 
situationally accessible memory system capturing sensory 
images whereas episodic memory is downregulated while 
under extreme stress.
Each of these implicit memory systems is associated 
with particular areas in the central nervous system. The 
hippocampus and the amygdala have been identified as 
playing roles in the storage and integration of memories.14,15 
The hippocampus plays a role in new learning formation, 
consolidation of information from short-term memory to 
encoding, and retrieval of long-term memories.10,11 For 
example, declarative memories are initially stored in the 
hippocampus and associated limbic structures as episodic 
memories; when integrated into the semantic system, it is 
hypothesized that hippocampal memory traces are weak-
ened, resulting in a decrease in associated affect and PTSD 
symptoms.13
A deficit in the capacity for new learning and memory 
becomes critical to the stress response in regard to being 
able to assess potential threats as well as the response to 
current and future situations.9,11 MRI scans have shown a 
reduction in volume of the hippocampus in individuals with 
PTSD; however, other evidence suggests a decreased hip-
pocampal volume may predispose individuals to PTSD.14,16 
Both animal and human studies identify stress, particularly 
chronic stress, as a potential cause of neural damage to 
the hippocampus.14,16–18 Neural damage may occur in the 
hippocampus due to increased levels of glucocorticoids, 
eg, cortisol and corticosterone, which are stress hormones 
aiding the fight and flight response and recovery from 
stressors,19 but inhibit neurogenesis and decrease levels of 
brain-derived neurotropic factor during and following expo-
sure to a stressful event.17,20
The hippocampus has a high concentration of glucocorti-
coid receptors, which can remain at high levels for days fol-
lowing the stress response. This appears to evoke a decrease in 
dendritic branching, alterations in synaptic terminal structure, 
loss of neurons, and inhibition of neuronal regeneration, 
resulting in hippocampal atrophy.17,20,21 As the hippocampus 
mediates memory functions, hippocampal atrophy may lead 
to memory deficits and result in memories being experienced 
as timeless and fragmented.10,22
The amygdala stores the emotional content linking epi-
sodic memories to emotions, resulting in the original sensa-
tions and emotions replaying when memories are recalled.13 
The amygdala has been identified as playing a critical role 
in stress responses, including fear acquisition, emotional 
regulation, and learning, conditioning, generalization, and 
extinction processes of the fear response mechanism.23–26 
Alterations in fear response are proposed to lead to intru-
sive memories, flashbacks, and automatic hyperarousal, 
with avoidance and emotional numbing reactions acting as 
coping strategies for such symptoms.23,24 Many subregions 
of the amygdala are proposed to influence the fear response 
involved in the symptomatology of PTSD (see Table 1), 
and other systems project to these amygdala subregions. 
One of these systems is the medial prefrontal cortex. The 
medial prefrontal cortex is understood to provide a system of 
negative feedback to the amygdala, that regulates activation 
of amygdala during fearful experiences.27 Studies by Semple 
et al28 and Shin et al27 have found a decrease in medial pre-
frontal cortex activity and associated hyperactivation of the 
amygdala in individuals with PTSD. Amygdala hyperactiv-
ity, or an exaggerated response, has been proposed to result 
in a failure of extinction to fearful stimuli.23,27,29
Chronic stress that causes dendritic atrophy in the hip-
pocampus elicits hypertrophy in subregions of the amygdala, 
increasing amygdala volume.26,30 Unlike the hippocampus 
that demonstrates relatively rapid plasticity, animal research 
indicates that the hypertrophy in the amygdala remains for 
a much longer duration, and may result in heightened levels 
of anxiety over time.31 Hyperactivity of the amygdala in 
PTSD may also be due to the exaggerated response of the 
fear circuitry, thereby explaining hypervigilance and hyper-
arousal in PTSD.





Table 1 Brain structures and their proposed function in PTSD symptomatology
Brain structure Proposed function
BLA and iTC (GABAergic  
neurons lying between  
the BLA and CeA)
Suggested to be responsible for both initiating and inhibiting fear responses.32 The BLA plays a role in sensory 
integration by sending information to both the CeA and the bed nucleus of the stria terminalis. These structures 
are thought to communicate with the hypothalamic and brainstem areas which are involved in fear and stress 
responses.33
Anterior cingulate gyrus May play a role in filtering and aiding integration of emotional and cognitive components, possibly aiding 
modulation of fight/flight reactions to perceived threat.10
CeA The main output center for responses to fearful stimuli.23,34 The CeA mediates the initiation of fear responses; 
when this area is removed in animals, the fear response is nonexistent.32
Corpus callosum An area of interest due to its involvement in the transfer of information across both hemispheres, integrating 
emotions and cognitive responses.10,35
Frontal lobes Act as a supervisory system for integration of information.36
HPA A hormonal flow traveling from the hypothalamus to the adrenal glands, via the pituitary gland. The hippocampus is 
thought to have inhibitory effects on the HPA axis, while the amygdala is thought to regulate the HPA via excitatory 
signals.32
Parahippocampal gyrus region May have heightened influence from the amygdala during an emotionally arousing learning situation.14
Abbreviations: BLA, anterior basolateral nuclei; CeA, central nucleus of the amygdala; HPA, hypothalamic-pituitary adrenal axis; iTC, intercalated cells; PTSD, post-
traumatic stress disorder.
Comorbid disorders
Ensuring that neurobiological research is methodologically 
sound is difficult, partly due to the presence of comorbid 
disorders in individuals with PTSD. Research suggests 
that comorbidity with PTSD is the rule rather than an 
exception. For example 63% of (veterans) who developed 
PTSD following a traumatic event also had a diagnosis 
of major depressive disorder, panic attacks, generalized 
anxiety disorder, or substance use disorder.32 In comparison 
these disorders were only present in 9% of those who did 
not develop PTSD. Teasing apart the symptomatology of 
comorbid disorders has proven complicated because there 
is mixed understanding as to whether they are independent 
disorders or part of one construct.33 Features traversing 
PTSD, major depressive disorder, generalized anxiety 
disorder, and substance use disorder include anhedonia, 
sleep disturbances, concentration difficulties, irritability 
and fatigue, low mood, agitation, guilt, withdrawal, and 
loss of enjoyment in activities.3,34
On a neurobiological level, a number of similar struc-
tures have been identified as possible underlying factors for 
several comorbid disorders and PTSD. Smaller hippocampal 
volumes have been found in individuals with major depres-
sive disorder, anxiety, and alcohol abuse,35 with research 
suggesting prolonged glucocorticoid exposure as a possible 
cause.36 Thus, the development of major depressive disorder, 
generalized anxiety disorder, and PTSD may be influenced 
by pre-existing, overlapping, or common vulnerabilities, such 
as neuroticism, a history of pre-existing mood or anxiety 
disorder, a history of trauma, or neurobiological differences. 
However, these disorders have a unique constellation of 
symptomatology, with PTSD requiring a distressing event to 
meet diagnosis and studies suggesting that PTSD is distin-
guishable due to features such as reliving/flashbacks, frag-
mentation of memories, and dissociative features, enabling 
a separate diagnosis.34,37,38
The prevalence of substance abuse disorders among 
individuals diagnosed with PTSD has been shown to be 
as high as 40% in samples of those seeking treatment for 
substance abuse.39 Substance use can follow PTSD, and 
this behavior has been described as “self-medicating”.40 
PTSD with a comorbid substance use disorder has been 
shown to increase the complexity of the clinical presenta-
tion through increased severity, increased risk of anxiety 
and personality disorders, high-risk behaviors resulting in 
risk of exposure to traumatic experiences, high treatment 
attrition rates, and less engagement with aftercare.40–42 
If PTSD is untreated, the prognosis for substance use 
disorder is poor and the probability of exposure to future 
traumatic events is higher.43 Once a comorbid diagno-
sis is established, treatment models incorporating both 
PTSD treatment and relapse prevention models are most 
successful.44,45
Traumatic brain injury, physical injury, and chronic pain 
are also commonly associated with PTSD. Corresponding 
symptoms of PTSD and traumatic brain injury include sleep 
disturbance, irritability, fragmented memories, difficulties 
concentrating, and haziness (appearing like dissociation).46,47 
From a therapeutic perspective, accurate diagnosis is often 
difficult as traumatic brain injury can be challenging to 
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detect, being a normal response in some circumstances; 
however, if present, it can interfere with the ability to process 
the traumatic event during treatment. Clearly identifying 
the presence of traumatic brain injury is important to ensure 
successful treatment.
The literature indicates chronic pain and PTSD comorbidity 
rates of 20%–50%.48,49 Chronic pain and PTSD present with 
overlapping symptoms of fatigue, cognitive distortions, anxiety 
sensitivity, experiential avoidance, hypervigilance, and sleep 
disturbance.48,50 Such symptoms may be both predisposing 
and maintaining for each disorder. A cyclical fear-avoidance 
process often occurs with chronic pain in which the fear of pain 
produces a catastrophic misinterpretation of bodily sensations 
and cognitive distortions/catastrophic appraisals.48 This then 
leads to avoidance behaviors and inactivity, resulting in dis-
ability and an increase of focus on pain intensity, perpetuating 
further avoidance and anxiety.48 Pedler and Sterling51 found 
an interaction between pain, disability, PTSD symptoms, and 
sensory hypersensitivity that resulted in the pain cycle being 
triggered continually. Pain can act as a trigger for intrusive 
symptoms of PTSD, resulting in increased emotional distress, 
more intense feelings of pain, and heightened avoidance 
strategies and immobility.51 On a neurobiological level, it has 
been hypothesized that pain and PTSD have similar neurobio-
logical mechanisms, such as an abnormal stress response and 
hypothalamic-pituitary-adrenal axis deregulation.48
Treatments of PTSD
The complexities in the profile of PTSD are evident at both 
a psychological and neurobiological level. These same 
complexities influence treatment models for PTSD. Current 
literature suggests that trauma-focused cognitive behavioral 
therapy, exposure therapies, and EMDR are the most effica-
cious treatments. However, almost half of the individuals 
treated for PTSD do not fully recover.52,53 Understanding the 
processes involved in PTSD and at work during treatment aids 
our ability to improve the rate of recovery. Early understand-
ings of PTSD processes was driven by behavioral theories 
that were based on conditioning and learning principles. It 
was thought that preventing avoidance of fear triggers would 
result in habituation and extinction, thereby alleviating PTSD 
symptoms.54,55 However, it has since been suggested that this 
model does not consider non-fear elements, such as shame, 
guilt, and anger.56 Research has now evolved beyond the 
fear response to the way distressing memories are processed, 
integrated, and represented.1,55
Information-processing theories hypothesize that process-
ing memories so that resolution of the meaning of the event 
takes place is a more successful theoretical and subsequent 
treatment model for PTSD than models based on learning 
theory.54,57 Emotional processing, cognitive models, dual 
representation, and adaptive information processing all fall 
under the banner of information-processing theories.55 More 
specifically, EMDR evolved under the adaptive information-
processing theory.58 EMDR was built on the understanding 
that processing the meaning of the event through integration 
of memories into an individual’s autobiographical memory 
would help to alleviate PTSD symptoms.58 EMDR has been 
verified as an effective treatment for PTSD and meets cri-
teria for evidence-based practice in the UK by the National 
Institute for Clinical Excellence (2005), in Australia by the 
Australian Centre for Posttraumatic Mental Health (2013), 
and in the Netherlands by the Dutch National Steering 
Committee for Guidelines for Mental Health Care (2003). 
EMDR is also listed in the World Health Organization 
guidelines for PTSD.
Research suggests that EMDR, although equal in achiev-
ing overall symptom reduction, may be superior to other 
treatment models in terms of treatment efficiency.59–62 Some 
studies have found that EMDR results in more rapid symptom 
reductions than other comparable treatment models, which in 
turn results in fewer treatment sessions required for the same 
outcome in comparison with other types of therapy.63–66 The 
rapid reduction in symptoms may be due to a large drop in 
intrusive symptoms in EMDR. Lee et al60 and Vaughan et al62 
found a greater decrease in intrusive symptoms in comparison 
with stress inoculation training with prolonged exposure, 
imaginal exposure, or applied muscle relaxation.
Ironson et al59 reported a significant difference in reduc-
tion of Subjective Units of Distress Scale scores following the 
first active session of EMDR in comparison with prolonged 
exposure. It was suggested in this study that prolonged expo-
sure was more distressing, particularly in the first session, 
than EMDR. Several studies have shown fewer dropouts in 
EMDR groups, leading to the proposition that EMDR is both 
better tolerated and a more efficient treatment model.59,61,67 
EMDR has been shown to be effective without the prescrip-
tion of several hours of homework which is most often 
required in exposure-based treatments, again contributing 
to the view that it is better tolerated and more efficient.59,67,68 
Nevertheless, there is some difficulty in interpreting research 
on treatment efficiency due to the differences in the way 
efficiency has been operationalized (for example, number of 
sessions taken to reduce symptoms, reduction in Subjective 
Units of Distress Scale scores in the first session, attrition 
rates, and number of treatment hours required). Thus, more 





extensive research is required to clarify the advantages of 
EMDR in terms of treatment efficiency.
Studies have shown that complex trauma cases require 
more sessions for symptom reduction than single case 
traumas; single case traumas have been shown to result 
in no longer meeting a diagnosis of PTSD after just a few 
sessions of EMDR.59 There are currently few randomized 
controlled trials involving individuals with complex histories 
of trauma. Hence, the efficacy and efficiency of symptom 
reduction in a complex population both immediately follow-
ing and after long-term use of EMDR is unclear. Lee et al63 
suggested that when comorbidity and chronicity are part of 
the treatment presentation, avoidance strategies or larger 
more entrenched memories may render fear networks more 
resistant to modification. With the rate of comorbid disorders 
being high in PTSD, and complex histories often emerging 
in a clinical setting, continued research is required in this 
complex trauma population to clarify the effectiveness and 
efficiency of EMDR.
The role of psychopharmacological treatment in PTSD 
is limited based on current evidence, with current guidelines 
indicating drug treatment to be second-line after trauma-
focused psychotherapy.69 Selective serotonin reuptake inhibi-
tors, including sertraline and paroxetine, are most commonly 
prescribed to reduce PTSD symptoms and prevent relapse, 
although current evidence indicates these medications alone 
result in only modest effect.70 There is some evidence that 
other classes of antidepressants, such as tricyclics and mono-
amine oxidase inhibitors, can be effective in the treatment of 
PTSD; however, the adverse effects/benefit ratio is generally 
seen to favor selective serotonin reuptake inhibitors.71
There is very little evidence to support the use of mood 
stabilizers (such as lithium or sodium valproate) or benzodi-
azepines in the treatment of PTSD. Prazosin and clonidine, 
which decrease adrenergic activity in the central nervous 
system, have been shown to reduce night-time and daytime 
PTSD symptoms, and there is some evidence that the more 
sedating atypical antipsychotic agents, such as olanzapine, 
quetiapine, and risperidone, can help as adjunctive treat-
ments in reducing symptoms of hyperarousal.70 Medications 
have been seen to reduce symptoms of PTSD; however, the 
literature identifies they should not replace evidence-based 
psychotherapies as a primary treatment unless patients are 
unable or unwilling to engage in therapy.72
EMDR processes
As in other therapies, the precise mechanisms of change 
are unknown in EMDR. There have been various arguments 
in the literature as to the differences between EMDR and 
trauma-focused cognitive behavioral therapy or exposure-
based models of treatment. Both models can be viewed in 
the light of information-processing theories; both address the 
individual’s troubling memories and personal meanings of the 
event and its consequences through having the client focus on 
the distressing event.52,73 Both models adhere to theories of 
fear structures as they both activate the fear memory network 
through presentation of information that matches elements 
of the fear structure and introduce corrective information 
incompatible with these elements.74,75
Although EMDR and traditional models of exposure 
show some common elements, there are clear differences. 
Imaginal exposure guides the individual to repetitively relive 
the traumatic experience as vividly as possible without mov-
ing to other memories or associations.74 This “flooding” 
approach is based on the theory that anxiety is caused by 
conditioned fear and reinforced by avoidance.67,74 In contrast, 
EMDR progresses through chains of associations that appear 
to be linked to shared sensory, cognitive, or emotional states 
in a non-directive way. The individual is encouraged to “let 
whatever happens happen and just notice” when freely associ-
ated memories enter into the mind though imaginal exposure 
in short bursts.66,76 According to traditional conditioning 
theories, promoting attention to the fear-relevant information 
facilitates activation, habituation, and modification of the 
fear structure; treatments that distract from this should be 
ineffective.77,78 Nevertheless, EMDR is effective.
During EMDR, the therapist often accesses only brief 
details of the trauma memory, and encourages image 
distortion/distancing which, according to traditional theories, 
should result in cognitive avoidance.74 EMDR treatment 
encourages distancing effects that are considered effective 
processing of the memory rather than cognitive avoidance.74 
This process may contribute to individuals reporting EMDR as 
less confronting and may explain why it is better tolerated.67
EMDR encompasses the complex emotional responses 
following a distressing event by looking at affect, physi-
cal sensations, cognitions, and emotions and beliefs 
concurrently.74 The cognitive shifts that EMDR evokes show 
that the client can access corrective information and link it to 
the trauma memory and other associated memory networks 
with little, if any, guidance.74 It seems that the integration 
of both positive and negative material that occurs spontane-
ously during the desensitization process of EMDR resembles 
assimilation into cognitive structures (in line with adaptive 
information-processing theory) such as world views, values, 
beliefs, and self-appraisals.55,75
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Overall, EMDR has challenged the theoretical grounds 
and understandings of historical treatment models for PTSD. 
The eye movement component has drawn a large amount of 
debate as this seems to be the component that differentiates 
EMDR from trauma-focused cognitive behavioral therapy 
and exposure-based treatments. However, it has been sug-
gested that eye movements are not necessary, with the 
research being mixed as to whether other bilateral stimulation 
(auditory or tactile) or no eye movements produce equivalent 
results.79–82 Based on fear extinction models, the eye move-
ments should cause distraction and decrease habituation. 
Lee and Cuijpers83 conducted a meta-analysis to determine 
the efficacy of eye movements when processing emotional 
memories. Their results supported the inclusion of eye 
movement in both treatment and laboratory environments, 
and demonstrated the importance of treatment fidelity when 
implementing EMDR.83,84
The proposed advantages of the extra task of eye 
movements in EMDR are distancing and a reduction of the viv-
idness and emotionality of the memory.85 Based on the theory 
that PTSD symptoms result from a failure to process episodic 
memories, it is suggested that the bilateral eye movements may 
facilitate interhemispheric interaction, resulting in improved 
processing of the memory.86 Research indicates that episodic 
memory processing is bilateral, whereas semantic memory 
processing is conducted in the left hemisphere of the brain.86,87 
Horizontal eye movement may enforce an increase in activa-
tion of both hemispheres, increasing communication between 
them and promoting processing by boosting the capacity to 
recall all elements of the event from episodic and semantic 
memories.86 Conflicting research, such as that produced by 
Propper et al,88 showed that engaging in bilateral eye move-
ments during EMDR resulted in decreased interhemispheric 
gamma electroencephalogram coherence (which is associated 
with episodic memory processing).
Other proposed theoretical models are based on rapid 
eye movement (REM) sleep and orienting response models. 
Research suggests that integration of episodic memories to 
semantic memories occurs during sleep.13 Brain research 
has demonstrated specific brain regions that are affected 
by the restimulation of traumatic memories in PTSD; these 
are the same regions activated in the REM phase of sleep.13 
The repeated bilateral eye movements are thought to activate 
the brain stem into a REM sleep state, thus supporting mem-
ory integration and a reduction in PTSD symptoms.13,89
The same repetitive bilateral stimulation reorienting 
attention from one side to another is also proposed to activate 
a similar neurological mechanism to REM sleep through an 
orienting response.10 Activation of these mechanisms shifts 
the brain into a “memory processing mode” similar to REM 
sleep, permitting the integration of traumatic memories.10,13,90 
It has also been proposed that eye movements trigger the 
orienting response by activating an “investigatory reflex” 
that is firstly an alert response and then a reflective pause 
that produces dearousal if there is no real threat.91 This reflex 
response results in heightened alertness which is proposed 
to permit exploratory behaviors where cognitive processes 
become more flexible and efficient, allowing the traumatic 
memory to be integrated.92 The eye movements are proposed 
to create a relaxation response, facilitating reprocessing of 
memories by decreasing distress.55,93
Under a working memory model it has been hypothesized 
that the positive effects from EMDR result from the eye 
movements creating a dual attention task. In line with the 
working memory model proposed by Baddley,94 working 
memory has limited capacity. When dual attention is required, 
the quality of the trauma image deteriorates, resulting in it 
being pushed out of working memory and integrated into 
long-term (semantic) memory where vividness and emotion-
ality are reduced.80,82,95 The dual task of holding the emotion 
in mind while focusing on bilateral eye movements may 
disrupt the storage of traumatic memories, decreasing the 
episodic quality of the memory and therefore decreasing the 
symptoms of PTSD.58,85 More specific exploration by Gunter 
and Bodner80 resulted in the proposition that memories 
held in the visuospatial sketchpad (a subsystem of working 
memory) decrease in vividness when eye movements deplete 
processing resources. Research has shown that a reduction in 
vividness of the memory, proposed to be due to eye move-
ments, may result in a subsequent decrease in emotionality 
around the memory and a corresponding decrease in PTSD 
symptoms.85 More research is required to verify a causal 
relationship between the level of vividness and consequent 
changes in emotionality.
Overall, key processes underlying EMDR mechanisms 
are complex in line with the treatment structure, which 
involves components of mindfulness, cognitive restructuring, 
exposure to the memory, and a sense of personal mastery.75 
A few studies have assessed neurobiological changes pre and 
post EMDR treatment to begin to establish structural and 
functional changes that may occur. Lansing et al96 found a 
decrease in the left and right occipital lobe, left parietal lobe, 
and right precentral lobe, and increased perfusion in the left 
inferior frontal gyrus for participants following an average 
of 10.25 hours of EMDR. Similarly, single-photon emis-
sion computed tomography results showed normalization of 





cerebral blood flow in the parieto-occipital, visual cortex, and 
hippocampus, and an increased cerebral blood flow in the 
prefrontal cortex in participants receiving EMDR.97
Electroencephalography has been used to monitor 
neuronal activation while actively engaged with bilateral 
eye movements.98 Participants in the study by Pagani et al 
were found to have activation in the prefrontal regions, 
limbic regions, fusiform and visual cortex, ie, areas that 
have been associated with decreases in negative emotional 
experiences.98 This study supports the hypothesis that EMDR 
works by moving the memory from an implicit subcortical 
to an explicit status where different cortical regions work to 
process the experience.
Lower gray matter density has been found in individuals 
with symptomatic PTSD (n=21) compared with individuals 
who have asymptomatic PTSD (n=22) in the left posterior 
cingulate (possibly influencing retrieval of autobiographical 
memories and relation to self) and left posterior parahip-
pocampal gyrus.99 In a second part of this study, 15 of the 
symptomatic participants received EMDR. The results 
showed that participants who responded well to EMDR 
(n=10) exhibited a proportional increase in gray matter 
density in the bilateral posterior cingulate as well as ante-
rior insula and right anterior parahippocampal gyrus when 
compared with non-responders. Nardo et al99 proposed that 
structural changes in these areas may influence the ability to 
cognitively reappraise and to integrate emotions and body 
sensation, resulting in non-response to EMDR.
Future directions and conclusion
PTSD is a complex disorder, and underlying mechanisms 
continue to be explored and understood. Neurobiological 
research is in its infancy; although it is already adding to 
the understanding of processes driving PTSD, there is mixed 
evidence supporting any one theory or neurobiological site. 
Future research exploring pre- and posttreatment structural 
and functional changes is required to support the hypotheses 
currently being suggested, and to explore specific areas of 
the amygdala, hippocampus, and the prefrontal cortex. It is 
vital that a methodological benchmark be set for such studies, 
because the various methods used are producing inconsis-
tencies and some confusion regarding already complicated 
research models.
EMDR has demonstrated effectiveness and efficiency in 
the treatment of PTSD, and future research and directions 
for EMDR are abundant. The evidence to date suggests that 
traditional exposure-based therapy models and EMDR have 
different processes, both theoretically and when reviewing 
the processes of each treatment model. Theories and research 
looking at the function and structure of the memory system 
in relation to its role in PTSD and in EMDR continue to 
evolve. Recent areas of interest are the visuospatial sketchpad 
(processing visuospatial information) and the phonological 
loop (processing verbal information), which may lead to 
further clarification of the mechanisms of EMDR.80,82 Further 
exploration of the role of eye movements in EMDR, and what 
mechanisms they activate when contributing to symptom 
reduction, is necessary.
Further research on outcomes research looking at treatment 
efficiency, particularly in a population that presents with com-
plex trauma, is necessary. Efficiency is imperative in clinical 
settings where government and private funding models only 
allow a minimum number of sessions, and attrition rates are 
high in many settings. Hence, the potential of EMDR as a 
superior treatment model based on efficacy and efficiency is 
of critical importance and requires methodologically strong 
research to ensure that clinicians can make a clear choice in 
the treatment model they use. Research in children and adoles-
cents is sparse, with comparative outcome studies required to 
determine the effectiveness of EMDR in this population.
EMDR is also in the early stages of being identified as a 
type of treatment for attachment disorders, grief, nightmares, 
other anxiety disorders, and substance disorders. Research to 
date is limited, but the results available indicate that comor-
bid disorders may also respond to EMDR. It is important to 
explore the potential of EMDR to provide clinicians with a 
treatment model that can traverse many symptom presenta-
tions in an efficient manner.
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